Christoph Westphal of CAMBRIDGE, MA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. Christoph Westphal appears on 13 filing roles across Form D (12), Form ADV (1).
| Filed | Source | Entity | Role | Location |
|---|---|---|---|---|
| 2025-03-25 | Form ADV | LONGWOOD MANAGEMENT LLC | MANAGING MEMBER | BOSTON, MA |
| 2011-11-21 | Form D | Verastem, Inc. | Director | CAMBRIDGE, MA |
| 2014-08-06 | Form D | Salarius Pharmaceuticals, Inc. | Director | Houston, TX |
| 2016-07-11 | Form D | Longwood Fund IV, L.P. | Executive Officer | BOSTON, MA |
| 2020-07-01 | Form D | Longwood Fund V, L.P. | Executive Officer | BOSTON, MA |
| 2020-08-13 | Form D | Werewolf Therapeutics, Inc. | Director | CAMBRIDGE, MA |
| 2021-01-28 | Form D | TScan Therapeutics, Inc. | Director | Waltham, MA |
| 2019-07-12 | Form D | Pyxis Oncology, Inc. | Director | Cambridge, MA |
| 2021-01-13 | Form D | ImmuneID, Inc. | Executive Officer | BOSTON, MA |
| 2022-09-22 | Form D | Longwood Fund VI, L.P. | Executive Officer | BOSTON, MA |
| 2021-08-24 | Form D | Immunitas Therapeutics, Inc. | Director | WALTHAM, MA |
| 2024-12-19 | Form D | Longwood Special Situations Fund, L.P. | Executive Officer | BOSTON, MA |
| 2025-02-24 | Form D | Newleos Therapeutics, Inc. | Director | BOSTON, MA |